Spending And Service Use Among People With The Fifteen Most Costly Medical Conditions, 1997
- 1 March 2003
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 22 (2), 129-138
- https://doi.org/10.1377/hlthaff.22.2.129
Abstract
This study addresses the Institute of Medicine’s recommendation that AHRQ use MEPS data to identify a set of priority conditions to inform efforts at improving quality of care. Using MEPS data we identify the fifteen most expensive conditions in the U.S. in 1997: chronic diseases such as heart disease, cancer, and diabetes, and acute conditions such as trauma, pneumonia, and infectious disease. Comorbidities were also associated with increased expenses. Type-of-service and source-of-payment distributions varied considerably across this set of conditions. Our findings highlight some of the challenges likely to be encountered in efforts to reform the current system.Keywords
This publication has 6 references indexed in Scilit:
- The Most Expensive Medical Conditions In AmericaHealth Affairs, 2002
- Inflation Spurs Health Spending In 2000Health Affairs, 2002
- Comparing The National Economic Burden Of Five Chronic ConditionsHealth Affairs, 2001
- Are The Benefits Of Newer Drugs Worth Their Cost? Evidence From The 1996 MEPSHealth Affairs, 2001
- The Concentration Of Health Care Expenditures, RevisitedHealth Affairs, 2001
- Medical Care Expenditures for Diabetes, Its Chronic Complications, and Its ComorbiditiesPreventive Medicine, 1999